A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A. Amarilla, Alexander A. Khromykh, Fasséli Coulibaly et al.|Nature Communications|2021Cited by 177
A broadly protective antibody that targets the flavivirus NS1 proteinNaphak Modhiran, Daniel Watterson, Hao Song et al.|Science|2021Cited by 124
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2Alberto A. Amarilla, Daniel Watterson, Naphak Modhiran et al.|Frontiers in Microbiology|2021Cited by 69
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Clinical & Translational Immunology|2021Cited by 62
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccineChristopher L. D. McMillan, David A. Muller, Jovin J. Y. Choo et al.|Science Advances|2021Cited by 47